NEW YORK (GenomeWeb News) – McKinley Scientific and New Objective today announced a co-marketing and development deal for the expansion of applications for liquid chromatography-mass spectrometry systems.

Sparta, NJ-based McKinley will provide financing and support services for mass spectrometry, while Woburn, Mass.-based New Objective is providing its nanospray front end technologies. Together, the firms will co-market their products and develop distribution and services to deliver mass spec solutions, they said.

Further financial and other details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.

A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.

Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.

Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."